Surgical management of extremity rhabdomyosarcoma: A consensus opinion from the Children's Oncology Group, the European Pediatric Soft‐Tissue Sarcoma Study Group, and the Cooperative Weichteilsarkom Studiengruppe-Reference-Cited by-同舟云学术

Surgical management of extremity rhabdomyosarcoma: A consensus opinion from the Children's Oncology Group, the European Pediatric Soft‐Tissue Sarcoma Study Group, and the Cooperative Weichteilsarkom Studiengruppe

Published:2020-08-09 Issue: Volume: Page:
ISSN:1545-5009
Container-title:Pediatric Blood & Cancer
language:en
Short-container-title:Pediatric Blood & Cancer

Author:

Morris Carol D.¹^ORCID,Tunn Per‐Ulf²,Rodeberg David A.³^ORCID,Terwisscha van Scheltinga Sheila⁴,Binitie Odion⁵,Godzinski Jan⁶,Dall'Igna Patrizia⁷^ORCID,Million Lynn⁸,Hawkins Douglas S.⁹,Koscielniak Ewa¹⁰,Bisogno Gianni¹¹^ORCID,Rogers Timothy N.¹²^ORCID

Affiliation:

1. Department of Orthopedic Surgery Johns Hopkins University School of Medicine Baltimore Maryland

2. Department of Orthopedic Oncology Helios Klinikum Berlin‐Buch Sarcoma Center Berlin‐Brandenburg Berlin Germany

3. Division Pediatric Surgery East Carolina University Greenville North Carolina

4. Pediatric Surgery, Pediatric Solid Tumor Unit Princess Máxima Center for Pediatric Oncology Utrecht the Netherlands

5. Sarcoma Department, Adolescent and Young Adult Program H. Lee Moffitt Cancer Center and Research Institute Tampa Florida

6. Department of Pediatric Surgery Marciniak Hospital, Wroclaw Poland and Department of Pediatric Traumatology and Emergency Medicine Medical University Wroclaw Poland

7. Pediatric Surgery Division, Department of Women's and Children's Health University of Padua Padua Italy

8. Department of Radiation Oncology Stanford University Medical Center Stanford California

9. Division of Hematology/Oncology Seattle Children's Hospital Fred Hutchinson Cancer Research Center University of Washington Seattle Washington

10. Klinikum Stuttgart Zentrum für Kinder Jugendund Frauenmedizin Olga Hospital, Pediatrics 5 (Pediatric Oncology Hematology and Immunology) Stuttgart Germany

11. Hematology and Oncology Division Department of Women's and Children's Health Padova University Hospital Padova Italy

12. Department of Pediatric Surgery University Hospitals Bristol NHS Foundation Trust Bristol United Kingdom

Publisher

Wiley

Subject

Oncology,Hematology,Pediatrics, Perinatology and Child Health

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/pbc.28608

Reference36 articles.

1. Analysis of Prognostic Factors in Patients With Nonmetastatic Rhabdomyosarcoma Treated on Intergroup Rhabdomyosarcoma Studies III and IV: The Children's Oncology Group

2. Prognostic Factors for Outcome in Localized Extremity Rhabdomyosarcoma. Pooled Analysis from Four International Cooperative Groups

3. Regional Nodal Involvement and Patterns of Spread Along In-Transit Pathways in Children With Rhabdomyosarcoma of the Extremity: A Report From the Children's Oncology Group

4. The International Neuroblastoma Risk Group (INRG) Staging System: An INRG Task Force Report

5. Paediatric Lymphadenopathy and #8211; A clinicopathological review.

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A rare case of perianal alveolar rhabdomyosarcoma;Clinical Case Reports;2024-09

2. Anlotinib destabilizes PAX3-FOXO1 to induce rhabdomyosarcoma cell death via upregulating NEK2;Biomedicine & Pharmacotherapy;2024-08

3. PET/CT and PET/MR in Soft Tissue Sarcoma: An Update;Seminars in Nuclear Medicine;2024-05

4. Risk factors for neurocognitive impairment, emotional distress, and poor quality of life in survivors of pediatric rhabdomyosarcoma: A report from the Childhood Cancer Survivor Study;Cancer;2024-02-19

5. Children's Oncology Group's 2023 blueprint for research: Surgery;Pediatric Blood & Cancer;2023-11-10